The Board denied the veteran's claims for service connection for prostatitis, cardiovascular disability, and stomach disability. The claim for an increased rating for dermatophytosis of the feet and groin was also denied.
The deciding factor: The RO found that there was no clear and unmistakable error in the January 1983 decision granting service connection for dermatophytosis of the feet with a noncompensable disability rating, and thus the veteran's claims were not well-grounded. The Board agreed with this determination.
- Claimed conditions
- prostatitis, cardiovascular disability, stomach disability
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- January 12, 2001
- Citation
- 0100947
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0100947.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board has remanded the claims for shin splints, right knee disability, acquired psychiatric disorder (depression), stomach disability, and left ear hearing loss due to errors in providing notice of the right to a hearing.
- Remanded (sent back)
The Board has remanded several issues related to the Veteran's claims for service connection, including sinusitis, sleep apnea, a stomach disability, left hand carpal tunnel syndrome, right hand carpal tunnel syndrome, and a back disability. The appeals are pending further examination or evidence.
- Dismissed
The appeal seeking to establish entitlement to a TDIU prior to July 30, 2019 and basic eligibility for DEA under 38 USC chapter 35 is dismissed as the pending Legacy system appeal fully encompasses and exceeds the scope of this AMA version of the issues.
- Remanded (sent back)
The Board has remanded the claims for diabetes, headaches, and a cardiovascular disability due to VA treatment on August 9, 2019. The Veteran contends that he was prescribed Jardiance (Empagliflozin) instead of Metformin, leading to complications such as DKA, renal failure, high blood pressure, irregular heartbeat, sleep apnea, dizziness, and headaches.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.